Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
WXSH0011
i
Other names:
WXSH0011
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(5)
News
Trials
Company:
WuXi AppTec
Drug class:
FGFR inhibitor, c-MET inhibitor
Related drugs:
‹
lenvatinib (90)
erdafitinib (70)
infigratinib (53)
futibatinib (52)
pemigatinib (41)
ABSK091 (32)
BAY 1163877 (23)
Debio 1347 (17)
ARQ 087 (12)
TKI258 (9)
ICP-192 (5)
CPL304110 (4)
E 3810 (4)
ABSK121 (3)
KIN-3248 (3)
AZ8010 (2)
tasurgratinib (2)
MPT0L145 (1)
PRN1371 (1)
EOC317 (0)
SSR 128129 (0)
SYHA1815 (0)
XL228 (0)
BAY 1179470 (0)
TAR-210 (0)
PI-88 (0)
TSU-68 (0)
SYHA1817 (0)
savolitinib (29)
amivantamab-vmjw (25)
tepotinib (24)
capmatinib (23)
TPX-0022 (8)
CKD-702 (6)
LY2801653 (6)
TQ-B3101 (6)
GB263T (5)
gumarontinib (5)
ARQ 197 (5)
REGN5093 (4)
MGCD265 (4)
AMG 102 (4)
envonalkib (3)
MCLA-129 (3)
ABN401 (3)
BPI-9016M (2)
HQP8361 (2)
HS-10241 (2)
S95027 (2)
APL-101 (2)
AV-299 (2)
GSK1363089 (2)
DO-1 (1)
GST-HG16 (1)
JNJ-38877605 (1)
KRC-108 (1)
SGX523 (1)
SU11274 (1)
LY2875358 (1)
E7050 (1)
RG3638 (1)
AL2846 (0)
AMG 208 (0)
AMG 337 (0)
ARGX-111 (0)
ASKC202 (0)
ASLAN002 (0)
DO-2 (0)
EMD 1204831 (0)
HLX55 (0)
MRX34 (0)
PF-04217903 (0)
PHA665752 (0)
PM1080 (0)
RXDX-106 (0)
S-49076 (0)
SAIT301 (0)
SAR 125844 (0)
SPH 3348 (0)
TAVO412 (0)
DCC-2701 (0)
Ami-LC (0)
EMB-01 (0)
BMS-794833 (0)
h224G11 (0)
XL092 (0)
lenvatinib (90)
erdafitinib (70)
infigratinib (53)
futibatinib (52)
pemigatinib (41)
ABSK091 (32)
BAY 1163877 (23)
Debio 1347 (17)
ARQ 087 (12)
TKI258 (9)
ICP-192 (5)
CPL304110 (4)
E 3810 (4)
ABSK121 (3)
KIN-3248 (3)
AZ8010 (2)
tasurgratinib (2)
MPT0L145 (1)
PRN1371 (1)
EOC317 (0)
SSR 128129 (0)
SYHA1815 (0)
XL228 (0)
BAY 1179470 (0)
TAR-210 (0)
PI-88 (0)
TSU-68 (0)
SYHA1817 (0)
savolitinib (29)
amivantamab-vmjw (25)
tepotinib (24)
capmatinib (23)
TPX-0022 (8)
CKD-702 (6)
LY2801653 (6)
TQ-B3101 (6)
GB263T (5)
gumarontinib (5)
ARQ 197 (5)
REGN5093 (4)
MGCD265 (4)
AMG 102 (4)
envonalkib (3)
MCLA-129 (3)
ABN401 (3)
BPI-9016M (2)
HQP8361 (2)
HS-10241 (2)
S95027 (2)
APL-101 (2)
AV-299 (2)
GSK1363089 (2)
DO-1 (1)
GST-HG16 (1)
JNJ-38877605 (1)
KRC-108 (1)
SGX523 (1)
SU11274 (1)
LY2875358 (1)
E7050 (1)
RG3638 (1)
AL2846 (0)
AMG 208 (0)
AMG 337 (0)
ARGX-111 (0)
ASKC202 (0)
ASLAN002 (0)
DO-2 (0)
EMD 1204831 (0)
HLX55 (0)
MRX34 (0)
PF-04217903 (0)
PHA665752 (0)
PM1080 (0)
RXDX-106 (0)
S-49076 (0)
SAIT301 (0)
SAR 125844 (0)
SPH 3348 (0)
TAVO412 (0)
DCC-2701 (0)
Ami-LC (0)
EMB-01 (0)
BMS-794833 (0)
h224G11 (0)
XL092 (0)
›
Associations
(5)
News
Trials
VERI cancer hierarchy
Reset Filters
FGFR overexpression + MET overexpression
Hepatocellular Cancer
FGFR overexpression + MET overexpression
Hepatocellular Cancer
WXSH0011
Sensitive: D – Preclinical
WXSH0011
Sensitive
:
D
WXSH0011
Sensitive: D – Preclinical
WXSH0011
Sensitive
:
D
MET overexpression
Hepatocellular Cancer
MET overexpression
Hepatocellular Cancer
WXSH0011
Sensitive: D – Preclinical
WXSH0011
Sensitive
:
D
WXSH0011
Sensitive: D – Preclinical
WXSH0011
Sensitive
:
D
FGFR overexpression
Hepatocellular Cancer
FGFR overexpression
Hepatocellular Cancer
WXSH0011
Sensitive: D – Preclinical
WXSH0011
Sensitive
:
D
WXSH0011
Sensitive: D – Preclinical
WXSH0011
Sensitive
:
D
FGFR overexpression
Gastric Cancer
FGFR overexpression
Gastric Cancer
WXSH0011
Sensitive: D – Preclinical
WXSH0011
Sensitive
:
D
WXSH0011
Sensitive: D – Preclinical
WXSH0011
Sensitive
:
D
MET overexpression
Gastric Cancer
MET overexpression
Gastric Cancer
WXSH0011
Sensitive: D – Preclinical
WXSH0011
Sensitive
:
D
WXSH0011
Sensitive: D – Preclinical
WXSH0011
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login